Key result
AF is the most common arrhythmia in HCM and requires early anticoagulation to prevent thromboembolism.
Why the study?
Atrial fibrillation is the most common sustained arrhythmia in patients with hypertrophic cardiomyopathy, requiring review of its mechanisms, therapeutic aspects, and prognostic impact.
This review summarizes the mechanisms, management, and prognostic implications of atrial fibrillation in patients with hypertrophic cardiomyopathy.
Answers are grounded in this paper and cite their sources.
Prompts early AF detection and anticoagulation in HCM; leaves optimal strategies open for prospective trials.
Fibrilace sn je nejastj setrvalou arytmi u pacient s hypertrofickou kardiomyopati. Souhrnn lnek se zabv komplexnmi mechanismy vedoucmi k rozvoji fibrilace sn u tto skupiny pacient a specifickmi aspekty jej terapie (zejmna antikoagulan terapie a pstupy k udren sinusovho rytmu). Zvren st je vnovna vlivu arytmie na klinickou symptomatologii a prognzu pacient s hypertrofickou kardiomyopati.
No takes yet. Share an insight, caveat, or question.
Puchnerová et al. (2024) conducted a review in Hypertrophic cardiomyopathy and atrial fibrillation. Atrial fibrillation is the most common sustained arrhythmia in patients with hypertrophic cardiomyopathy, requiring early diagnosis and adequate therapy, particularly anticoagulation, to prevent thromboembolic complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: